Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Hylek

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 19, 2015
Global public awareness of venous thromboembolismA M Wendelboe, M McCumber, E M Hylek, et al.
Archives of Internal Medicine|June 10, 2000
Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulationE M Hylek, Y C Chang, S J Skates, et al.
Thrombosis and Haemostasis|December 6, 2013
Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanismsC L Cove, C M Albert, F Andreotti, et al.
Journal of Thrombosis and Haemostasis : JTH|July 27, 2010
Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)A J Rose, E M Hylek, A Ozonoff, et al.
Annals of Internal Medicine|September 19, 2001
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarinE M Hylek, S Regan, A S Go, et al.
Annals of Internal Medicine|December 28, 1999
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) studyA S Go, E M Hylek, L H Borowsky, et al.
JAMA|May 10, 2001
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyA S Go, E M Hylek, K A Phillips, et al.
Journal of Thrombosis and Haemostasis : JTH|February 1, 2012
INR targets and site-level anticoagulation control: results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)A J Rose, D R Berlowitz, D R Miller, et al.
Circulation|July 6, 2000
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) studyA S Go, E M Hylek, K A Phillips, et al.
Journal of Thrombosis and Haemostasis : JTH|April 20, 2010
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin usersD M Witt, T Delate, N P Clark, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|June 19, 2015
Global public awareness of venous thromboembolismA M Wendelboe, M McCumber, E M Hylek, et al.
Archives of Internal Medicine|June 10, 2000
Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulationE M Hylek, Y C Chang, S J Skates, et al.
Thrombosis and Haemostasis|December 6, 2013
Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanismsC L Cove, C M Albert, F Andreotti, et al.
Journal of Thrombosis and Haemostasis : JTH|July 27, 2010
Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)A J Rose, E M Hylek, A Ozonoff, et al.
Annals of Internal Medicine|September 19, 2001
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarinE M Hylek, S Regan, A S Go, et al.
Annals of Internal Medicine|December 28, 1999
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) studyA S Go, E M Hylek, L H Borowsky, et al.
JAMA|May 10, 2001
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyA S Go, E M Hylek, K A Phillips, et al.
Journal of Thrombosis and Haemostasis : JTH|February 1, 2012
INR targets and site-level anticoagulation control: results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)A J Rose, D R Berlowitz, D R Miller, et al.
Circulation|July 6, 2000
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) studyA S Go, E M Hylek, K A Phillips, et al.
Journal of Thrombosis and Haemostasis : JTH|April 20, 2010
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin usersD M Witt, T Delate, N P Clark, et al.
Pageof 3